Literature DB >> 18279450

Establishing the role of cytokine therapy in advanced renal cell carcinoma.

Martin E Gore1, Pieter De Mulder.   

Abstract

Tribute to Professor Pieter De Mulder, from Martin Gore. Pieter and I were often pitted against each other in debates at international meetings on the role of cytokine therapy. The truth is that there was little disagreement between us, but we both thought such set pieces were a good way to highlight the issues surrounding the use of cytokines. He wanted our true joint view to be put on record, and the result is this article. Pieter himself suffered from kidney cancer for many years and he died in April as we were putting the finishing touches to this manuscript. Pieter was a remarkable man in so many ways. He was a physician of great compassion, immense intellect, utter integrity and unshakeable scientific rigor. These qualities meant that his perspective on many clinical controversies was in great demand internationally. The European oncology community has lost one of its giants and I, a dear friend. This manuscript is dedicated to the memory of Professor Pieter de Mulder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279450     DOI: 10.1111/j.1464-410X.2008.07435.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  2 in total

1.  Economic evaluation of first-line treatments for metastatic renal cell carcinoma: a cost-effectiveness analysis in a health resource-limited setting.

Authors:  Bin Wu; Baijun Dong; Yuejuan Xu; Qiang Zhang; Jinfang Shen; Huafeng Chen; Wei Xue
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

2.  Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.

Authors:  Laura Ridolfi; Francesco de Rosa; Ruggero Ridolfi; Giorgia Gentili; Linda Valmorri; Emanuela Scarpi; Elisabetta Parisi; Antonino Romeo; Massimo Guidoboni
Journal:  J Transl Med       Date:  2014-09-23       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.